
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Precautionary and Common Medicine</title>

    <!-- aos css file cdn link  -->
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/aos/2.3.4/aos.css">

    <!-- magnific popup css cdn link  -->
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/magnific-popup.js/1.1.0/magnific-popup.min.css">

    <!-- bootstrap cdn link  -->
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/4.5.3/css/bootstrap.min.css">

    <!-- font awesome cdn link  -->
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">

    <!-- custom css file link  -->
    <link rel="stylesheet" href="style.css">

</head>

<body>
    <!-- Header Showcase -->
    <header id="showcase" class="grid">
        <div class="bg-image"></div>
        <div class="content-wrap">
            <h1></h1>
            
            <h1><span>stay safe, stay healthy.</span></h1>
            <h4>caring for you.</h4>
            <a href="#section-b" class="btn">Read More</a>
     
        </div>
    </header>

    <!-- Main Area -->
    <main id="main">
        <!-- Section A -->
        <section id="section-a" class="grid">
            <div class="content-wrap">
                <h2 class="content-title">Medicinal Advisal page</h2>
                <h3>Introduction</h3>
                <div class="content-text">
                    <p>This website is made for helping purpose only</p>
                    <p>Medicines and dosage forms are listed in alphabetical order within each section and there is no implication of preference for one form over another. Standard treatment guidelines should be consulted for information on appropriate dosage forms.</p>
                    <p>The presence of an entry on the Essential Medicines List carries no assurance as to pharmaceutical quality. It is the responsibility of the relevant national or regional drug regulatory authority to ensure that each product is of appropriate pharmaceutical quality (including stability) and that when relevant, different products are interchangeable. </p>
            </div>
            </div>
        </section>

        <!-- Section B -->
        <section id="section-b" class="grid">
            <ul>
                <li>
                    <div class="card">
                        <img src="https://static.pexels.com/photos/574077/pexels-photo-574077.jpeg" alt="">
                        <div class="card-content">
                            <h3 class="card-title"> <a href="#content">Menu</a></h3>
                            <!-- <p>Lorem ipsum dolor sit amet consectetur adipisicing elit. Nostrum culpa neque quo eum et
                                quasi velit voluptatum cum maiores exercitationem.</p> -->
                        </div>
                    </div>
                </li>
                <li>
                    <div class="card">
                        <img src="https://static.pexels.com/photos/261628/pexels-photo-261628.jpeg" alt="">
                        <div class="card-content">
                            <h3 class="card-title"><a href="#facility">Facility</a></h3>
                            <!-- <p>Lorem ipsum dolor sit amet consectetur adipisicing elit. Nostrum culpa neque quo eum et
                                quasi velit voluptatum cum maiores exercitationem.</p> -->
                        </div>
                    </div>
                </li>
                <li>
                    <div class="card">
                        <img src="https://static.pexels.com/photos/265087/pexels-photo-265087.jpeg" alt="">
                        <div class="card-content">
                            <h3 class="card-title"><a href="#contact">Contact</a></h3>
                            <!-- <p>Lorem ipsum dolor sit amet consectetur adipisicing elit. Nostrum culpa neque quo eum et
                                quasi velit voluptatum cum maiores exercitationem.</p> -->
                        </div>
                    </div>
                </li>
            </ul>
        </section>
<!-- 
         Section C 
        <section id="section-c" class="grid">
            <div class="content-wrap">
                <h2 class="content-title">We handle all of your digital needs</h2>
                <p>Lorem ipsum dolor sit amet consectetur, adipisicing elit. Maxime nam rerum vel earum error fugiat
                    cupiditate, dolore eius! Minus, explicabo.</p>
            </div>
        </section> -->

       
    </main>

    <!-- Footer -->
    <!-- <footer id="main-footer" class="grid"> -->
        <!-- <div>Acme Web Solutions</div>
        <div>Project By <a href="http://traversymedia.com" target="_blank">Traversy Media</a></div> -->
    <!-- </footer> -->


<!-- header section starts  -->


<div class="container">
	
<!--    
        <ul>
		 <div class="fas fa-bars" ><h2>Menu</h2></div>

			 <nav class="nav"   >
		<img id="edit5"src="100.png"  width= "400px" >
    </nav>
        
            <li><a href="#home"><h2>Home</h2></a></li>
            <li><a href="#facility"><h2>Facility</h2></a></li>
            <li><a href="#contact"><h2>Contact</h2></a></li>
		
        </ul>
    -->
   



<!-- header section ends  -->

<!-- home section starts  -->


    

</div>


<section id="content" class="content"> 
<section>
    <!--This example uses the default bootstrap stylesheet-->
 <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css"
          integrity="sha384-BVYiiSIFeK1dGmJRAkycuHAHRg32OmUcww7on3RYdg4Va+PmSTsz/K68vbdEjh4u" crossorigin="anonymous">
<!--provides a full-width container that can expand or collapse based on the size of viewport-->
<div class="container-fluid">
    <div class="row" >
        <div class="col-md-2 col-sm-12 col-xs-12">
            <nav id="navbar">
				<nav>
                <h4 style = "background: linen;  color: black"  >Technical Documentation Index</h4>
				</nav>
                <!--content stacking for smaller screens-->
                <ul class="nav nav-pills nav-stacked">
                 <!--internal linking to the respective sections-->
                    <a class="nav-link" href="#Introduction" rel="internal" data-aos="fade-right">
                        <li><h4> - INTRODUCTION </h4></li>
                    </a>
                    <a class="nav-link" href="#top1" rel="internal"data-aos="fade-right">
                        <li><h4>1. ANASTHETIA FOR LOSS OF SENSE OR PAIN</h4></li>
                    </a>
                    <a class="nav-link" href="#top2" rel="internal"data-aos="fade-right">
                        <li><h4>2. MEDICINES FOR PAIN AND PALLIATIVE CARE</h4></li>
                    </a>
                    <a class="nav-link" href="#top3" rel="internal"data-aos="fade-right">
                        <li><h4>3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS</h4></li>
                    </a>
                    <a class="nav-link" href="#top4" rel="internal"data-aos="fade-right">
                        <li><h4>4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS</h4></li>
                    <a class="nav-link" href="#top5" rel="internal"data-aos="fade-right">
                        <li><h4>5. ANTICONVULSANTS / ANTIEPILEPTICS</h4></li>
                    </a>
                    <a class="nav-link" href="#top6" rel="internal"data-aos="fade-right">
                        <li><h4>6. ANTI-INFECTIVE MEDICINES</h4></li>
                    </a>
                    <a class="nav-link" href="#top7" rel="internal"data-aos="fade-right">
                        <li><h4>7. ANTIMIGRAINE MEDICINES</h4></li>
                    </a>
                    <a class="nav-link" href="#top8" rel="internal"data-aos="fade-right">
                        <li><h4>8. ANTINEOPLASTIC AND IMMUNOSUPPRESSIVES</h4></li>
                    </a>
                    <a class="nav-link" href="#top9" rel="internal"data-aos="fade-right">
                        <li><h4>9. ANTIPARKINSONISM MEDICINES</h4></li>
                    </a>
                    <a class="nav-link" href="#top10" rel="internal"data-aos="fade-right">
                        <li><h4>10. BLOOD PRODUCTS AND PLASMA SUBSTITUTES OF HUMAN ORIGIN</h4></li>
                    </a>
                    <a class="nav-link" href="#top11" rel="internal"data-aos="fade-right">
                        <li><h4>11. DERMATOLOGICAL MEDICINES (topal)</h4></li>
                    </a>
                    <a class="nav-link" href="#top12" rel="internal"data-aos="fade-right">
                        <li><h4>12. DIAGNOSTIC AGENTS</h4></li>
                    </a>
                    <a class="nav-link" href="#top13" rel="internal"data-aos="fade-right">
                        <li><h4>13. GASTROINTESTINAL MEDICINES</h4></li>
                    </a>
                    <a class="nav-link" href="#top14" rel="internal"data-aos="fade-right">
                        <li><h4>14. IMMUNOLOGICALS</h4></li>
                    </a>
                    <a class="nav-link" href="#top15" rel="internal"data-aos="fade-right">
                        <li><h4>15. VACCINES</h4></li>
                    </a>
                    <a class="nav-link" href="#top16" rel="internal"data-aos="fade-right">
                        <li><h4>16. DISINFECTANTS AND ANTISEPTICS</h4></li>
                    </a>
 
 
                    
                 </ul>
            </nav>
        </div>
        <div class="col-md-10 col-sm-12 col-xs-12">
            <main id="main-doc">
				<section class="main-section" id="intoduction" data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black"> - INTRODUCTION</h4>
                    <article>
                        <p>This is for helping purpose only</p>
						<p>Medicines and dosage forms are listed in alphabetical order within each section and there is no implication of preference for one form over another. Standard treatment guidelines should be consulted for information on appropriate dosage forms.</p>
						<p>The presence of an entry on the Essential Medicines List carries no assurance as to pharmaceutical quality. It is the responsibility of the relevant national or regional drug regulatory authority to ensure that each product is of appropriate pharmaceutical quality (including stability) and that when relevant, different products are interchangeable. </p>

<!-                 </article>
                </section>
                <section class="main-section" id="top1" data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">1.ANAESTHETICS </h4>
                    <article>
                        <p><h4>1.1.1 Injectable medicines </h4></p>
						<p>ketamine :	Injection: 50 mg (as hydrochloride)/ml in 10‐ml vial. </p>
						<p>propofol*:	Injection: 10 mg/ml;  20 mg/ml.</p>
						<p>* Thiopental may be used as an alternative depending on local availability and cost.</p>
						<p><h4>1.2 Local anaesthetics</h4></p>
						<p> bupivacaine 	Injection: 0.25%;  0.5% (hydrochloride) in vial.  </p>
						<p>Injection for spinal anaesthesia: 0.5% (hydrochloride) in 4ml ampoule to be mixed with 7.5% glucose solution. </p>
						<p> lidocaine 	Injection: 1%;  2% (hydrochloride) in vial. </p>
						<p>Injection for spinal anaesthesia: 5% (hydrochloride) in  2‐ml ampoule to be mixed with 7.5% glucose solution. </p>
						<p>topal forms: 2% to 4% (hydrochloride).</p>
						<p>lidocaine + epinephrine (adrenaline)  	Dental cartridge: 2% (hydrochloride) + epinephrine 1:80 000.</p>
						<p>Injection: 1%;  2% (hydrochloride or sulfate) + epinephrine 1:200 000 in vial. </p>
						<p><h4>Complementary List</h4></p>
						<p>ephedrine : Injection: 30 mg (hydrochloride)/ml in 1‐ml ampoule. </p>
						<p>(For use in spinal anaesthesia during delivery, to prevent hypotension).</p>
						<p><h4>1.3 Preoperative medication and sedation for short-term procedures </h4></p>
						<p>atropine 	Injection: 1 mg (sulfate) in 1‐ml ampoule. </p>
						<p> midazolam 	Injection: 1 mg/ml.; Oral liquid: 2 mg/ml [c]. ; Tablet: 7.5 mg;  15 mg. </p>
						<p>morphine 	Injection: 10 mg (sulfate or hydrochloride) in 1‐ml ampoule.</p>
						<!-                 </article>
                </section>
                <section class="main-section" id="top2"data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">2. MEDICINES FOR PAIN AND PALLIATIVE CARE </h4>
                    <article>
                        <p><h4>2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)</h4></p>
						<p>acetylsalicylic acid :	Suppository: 50 mg to 150 mg. Tablet: 100 mg to 500 mg. </p>
						<p>paracetamol* :	Oral liquid: 125 mg/5 ml.Suppository: 100 mg. Tablet: 100 mg to 500 mg. * Not recommended for anti-inflammatory use due to lack of proven benefit to that effect. </p>
						<p><h4>2.2 Opioid analgesics </h4></p>
						<p>codeine 	Tablet: 30 mg (phosphate).</p>
						<p>morphine*  :	Granules (slow‐release;  to mix with water): 20 mg 200 mg (morphine sulfate). Injection: 10 mg (morphine hydrochloride or morphine sulfate) in 1‐ml ampoule. Oral liquid: 10 mg (morphine hydrochloride or morphine sulfate)/5 ml. </p>
						<p>Tablet (slow release): 10 mg‐ 200mg (morphine hydrochloride or morphine sulfate).  Tablet (immediate release): 10 mg (morphine sulfate). </p>
						<p>*Alternatives limited to hydromorphone and oxycodone </p>
						<p><h4>2.3  Medicines for other common symptoms in palliative care: </h4> </p>
						<p>1. amitriptyline 2. cyclizine [c] 3. dexamethasone  4.diazepam  5.docusate sodium 6.fluoxetine a  7.haloperidol 8.hyoscine butylbromide 9.hyoscine hydrobromide [c] 10.lactulose [c]  11. loperamide 12. metoclopramide 13.midazolam 14.ondansetron [c] [a] 15. senna </p>
						
											
<!-                 </article>
                </section>
                <section class="main-section" id="top3"data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS </h4>
                    <article>
                        <p>dexamethasone 	Injection: 4 mg/ml in 1‐ml ampoule (as disodium phosphate salt). </p>
						<p>epinephrine (adrenaline) 	Injection: 1 mg (as hydrochloride or hydrogen tartrate) in 1‐ml ampoule. </p>
						<p>hydrocortisone 	Powder for injection: 100 mg (as sodium succinate) in vial. </p>
						<p>alternatives :  loratadine *  prednisolone</p>
					
						
<!-                 </article>
                </section>
                <section class="main-section" id="top4"data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS</h4>
                    <article>
                        <p><h4>4.1 Non-specific</h4> </p>
						<p>charcoal, activated 	Powder.</p>
						<p></h4>4.2 Specific </h4></p>
						<p>acetylcysteine 	Injection: 200 mg/ml in 10‐ml ampoule. </p>
						<p>Oral liquid: 10% [c];  20% [c]. </p>
						<p>atropine 	Injection: 1 mg (sulfate) in 1‐ml ampoule. </p>
						<p>calcium gluconate 	Injection: 100 mg/ml in 10‐ml ampoule. </p>
						<p>methylthioninium chloride  (methylene blue) 	Injection: 10 mg/ml in 10‐ml ampoule. </p>
						<p>naloxone 	Injection: 400 micrograms (hydrochloride) in 1‐ml ampoule. </p>
						<p>penicillamine 	Solid oral dosage form: 250 mg. </p>
						<p>potassium ferric hexacyano‐ferrate(II) ‐2H20 (Prussian blue) 	Powder for oral administration. </p>
						<p>sodium nitrite 	Injection: 30 mg/ml in 10‐ml ampoule. </p>
						<p>sodium thiosulfate 	Injection: 250 mg/ml in 50‐ml ampoule. </p>
						
<!-                 </article>
                </section>
                <section class="main-section" id="top5"data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">5. ANTICONVULSANTS / ANTIEPILEPTICS </h4>
                    <article>
                        <p>carbamazepine Oral liquid: 100 mg/5 ml.Tablet (chewable): 100 mg;  200 mg. Tablet (scored): 100 mg;  200 mg.</p> 	
						<p> diazepam : Gel or rectal solution: 5 mg/ml in 0.5 ml;  2ml;  4ml tubes. </p>
						</p>alternatives : 1. lorazepam 2.magnesium sulfate* 3. phenobarbital 4. phenytoin valproic acid (sodium valproate) </p>
						<p> Complementary List :  ethosuximide </p>
						
<!-                 </article>
                </section>
                <section class="main-section" id="top6"data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">6. ANTI-INFECTIVE MEDICINES </h4>
                    <article>
                        <p><h4>6.1 Anthelminthics </h4></p>
						<p><h4>6.1.1 Intestinal anthelminthics </h4></p>
						<p>albendazole 	Tablet (chewable): 400 mg.</p>
						<p>levamisole 	Tablet: 50 mg;  150 mg (as hydrochloride). </p>
						<p>mebendazole 	Tablet (chewable): 100 mg;  500 mg. </p>
						<p><h4>6.2 Antibacterials1</h4></p>
						<p><h4>6.2.1 Beta Lactam medicines </h4></p>
						<p>amoxicillin 	Powder for oral liquid: 125 mg (as trihydrate)/5 ml;  250 mg (as trihydrate)/5 ml [c]. Solid oral dosage form: 250 mg;  500 mg (as trihydrate). </p>
						<p>amoxicillin + clavulanic acid  	Oral liquid: 125 mg amoxicillin + 31.25 mg clavulanic acid/5 ml AND 250 mg amoxicillin + 62.5 mg clavulanic acid/5 ml [c]. ;  Tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt). </p>
						<p>alternatives : 1.ampicillin 2.benzathine benzylpenicillin 3.benzylpenicillin 4.cefalexin [c] 5. cefazolin* a 6.cefixime* </p>
						<p>6.2.2 <h4>Other antibacterials</h4></p>
						<p>1.azithromycin 2. azithromycin 3.ciprofloxacin* 4.clarithromycin* 5.doxycycline a 6. erythromycin 7. gentamicin 8. metronidazole 9.nitrofurantoin 10.spectinomycin </p>
						<p><h4>6.2.4 Antituberculosis medicines </h4></p>
						<p>WHO  recommends and endorses the use of fixed‐dose combinations and the development of appropriate new fixed‐dose combinations, including modified dosage forms, non‐refrigerated products and paediatric dosage forms of assured pharmaceutical quality.   </p>
						<p>ethambutol + isoniazid  	Tablet: 400 mg + 150 mg.</p>		
						<p>ethambutol + isoniazid + pyrazinamide + rifampicin  	Tablet: 275 mg + 75 mg + 400 mg + 150 mg. </p>
						<p><h4>6.3 Antifungal medicines </h4></p>
						<p>amphotericin B 	Powder for injection: 50 mg in vial (as sodium deoxycholate or liposomal complex). </p>
						<p>clotrimazole 	Vaginal cream: 1%;  10%.Vaginal tablet: 100 mg;  500 mg. </p>
						<p>flucytosine 	Capsule: 250 mg.Infusion: 2.5 g in 250 ml. </p>
						
<!-                 </article>
                </section>
                <section class="main-section" id="top7"data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">7. ANTIMIGRAINE MEDICINES </h4>
                    <article>
                        <p><h4>7.1 For treatment of acute attack</h4></p>
						<p>acetylsalicylic acid 	Tablet: 300 mg to 500 mg.</p>
						<p>paracetamol 	Oral liquid: 125 mg/5 ml Tablet: 300 mg to 500 mg.</p>
						<p><h4>7.2 For prophylaxis </h4></p>
						<p> propranolol 	Tablet: 20 mg;  40 mg (hydrochloride). /p>
					
						
<!-                 </article>
                </section>
                <section class="main-section" id="top8"data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">8. ANTINEOPLASTIC AND IMMUNOSUPPRESSIVES</h4>
                    <article>
                        <p><h4>8.1 Immunosuppressive medicines </h4></p>
						<p>Complementary List :</p>
						<p>azathioprine :Powder for injection: 100 mg (as sodium salt) in vial.Tablet (scored): 50 mg. </p>
						<p>ciclosporin 	Capsule: 25 mg. Concentrate for injection: 50 mg/ml in 1‐ml ampoule for organ transplantation. </p>
							
<!-                 </article>
                </section>
                <section class="main-section" id="top9"data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">9. ANTIPARKINSONISM MEDICINES </h4>
                    <article>
                        <p> biperiden 	Injection: 5 mg (lactate) in 1‐ml ampoule. Tablet: 2 mg (hydrochloride). </p>
						<p>levodopa +  carbidopa  	Tablet: 100 mg + 10 mg;  100mg+25mg;  250 mg + 25 mg  </p>
						
<!-                 </article>
                </section>
                <section class="main-section" id="top10"data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">10. BLOOD PRODUCTS AND PLASMA SUBSTITUTES OF HUMAN ORIGIN</h4>
                    <article>
                        <p>10.1 Blood and blood components </p>
						<p>WHO recognizes that achieving self‐sufficiency, unless special circumstances preclude it, in the supply of safe blood components based on voluntary, non‐remunerated blood donation, and the security of that supply are important national goals to prevent blood shortages and meet the transfusion requirements of the patient population.  All preparations should comply with the WHO requirements. :
						
						<p>fresh frozen plasma  ; platelet concentrates ;  red blood cells   ; whole blood   </p>
						<p><h4>10.2 Plasma-derived medicines</h4 ></p>
						<p>All human plasma derived medicines should comply with the WHO Requirements.  </p>
						
<!-                 </article>
                </section>
                <section class="main-section" id="top11"data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">11. DERMATOLOGICAL MEDICINES (topal) </h4>
                    <article>
                        <p><h4>11.1 Antifungal medicines</h4> </p>
						<p>miconazole 	Cream or ointment: 2% (nitrate). </p>
						<p>selenium sulfide 	Detergent‐based suspension: 2%. </p>
						<p>sodium thiosulfate 	Solution: 15%.</p>
						<p>terbinafine 	Cream: 1% or Ointment: 1% terbinafine hydrochloride. </p>
						<p><h4>11.2 Anti-infective medicines</h4></p>
						<p>mupirocin 	Cream (as mupirocin calcium): 2%. Ointment: 2%. </p>
						<p>potassium permanganate 	Aqueous solution: 1:10 000.</p>
						
<!-                 </article>
                </section>
                <section class="main-section" id="top12"data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">12. DIAGNOSTIC AGENTS </h4>
                    <article>
                        <p><h4>12.1 Ophthalmic medicines</h4> </p>
						<p>fluorescein 	Eye drops: 1% (sodium salt).</p>
						<p> tropicamide Eye drops: 0.5%.</p>
						<p><h4>12.2 Radiocontrast medi	a </h4> </p>
						<p>amidotrizoate Injection: 140 mg to 420 mg iodine (as sodium or meglumine salt)/ml in 20‐ml ampoule. </p>
						<p>barium sulfate 	Aqueous suspension.</p>
						
<!-                 </article>
                </section>
               

                <section class="main-section" id="top13"data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">13. GASTROINTESTINAL	 MEDICINES </h4>
                    <article>
                        <p>Complementary List 	[c]	</p>
						<p>	 pancreatic enzymes : Age‐appropriate formulations and doses including lipase, protease and amylase. </p>
						<p><h4>13.1 Antiulcer medicines	 </h4></p>
						<p> omeprazole Powder for oral liquid: 20 mg;  40 mg sachets.Solid oral dosage form: 10 mg;  20 mg;  40 mg. </p>
						<p>13.2 Anti-inflammatory 	medicines ulfasalazine 		Retention enema.Suppository: 500 mg. Tablet: 500 mg. </p>
						
<!-                 </article>
                </section>
                <section class="main-section" id="top14"data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">14. IMMUNOLOGICALS </h4>
                    <article>
                        <p><h4>14.1 Diagnostic agents</h4> </p>
						<p>All tuberculins should comply with the WHO Requirements for Tuberculins.</p>
						<p>tuberculin, purified protein derivative (PPD)	Injection.</p>
						<p><h4>14.2 Sera and immunoglobulins</h4> </p>
						<p>All plasma fractions should comply with the WHO requirements.</p>
						<p>anti-D immunoglobulin (human) 	Injection: 250 micrograms in single‐dose vial.</p>
						
						
<!-                 </article>
                </section>
                <section class="main-section" id="top15"data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">15. Vaccines</h4>
                    <article>
                        <p>Selection of vaccines from the Model List will need to be determined by each country after consideration of international recommendations, epidemiology and national priorities. The list below details the vaccines for which there is either a recommendation from the Strategic Advisory Group of Experts on Immunization (SAGE) (http://www.who.int/immunization/sage_conclusions/en/index.html) and/or a WHO position paper (http://www.who.int/immunization/documents/positionpapers/en/index.html). This site will be updated as new position papers are published and contains the most recent information and recommendations. </p>
						<p>All vaccines should comply with the WHO Requirements for Biological Substances.  </p>
						<p>WHO noted the need for vaccines used in children to be polyvalent. </p>
						<p>BCG vaccine 	; cholera vaccine 	; diphtheria vaccine 	; Haemophilus influenzae type b vaccine 	; hepatitis A vaccine 	; hepatitis B vaccine 	influenza vaccine 	; Japanese encephalitis vaccine 	'measles vaccine 	; meningococcal meningitis vaccine 	; mumps vaccine  	; pertussis vaccine 	; pneumococcal vaccine 	; poliomyelitis vaccine  	; rabies vaccine  	; rotavirus vaccine 	; rubella vaccine  	; tetanus vaccine  	; typhoid vaccine  	;  vaccine 	; yellow fever vaccine 	</p>
						
						
<!-                 </article>
                </section>
                 <section class="main-section" id="top16"data-aos="FADE-UP">
                    <h4 style = "background: linen;  color: black">16. DISINFECTANTS AN	D ANTISEPTICS</h4>
                    <article>
                        <p><h4>16.1 Antiseptics</h4> </p>
						<p> chlorhexidine 		Solution: 5% (digluconate). </p>
						<p> ethanol 		Solution: 70% (denatured).</p>
						<p> polyvidone iodine : Solution: 10% (equivalent to 1% available iodine).</p>
						<p><h4>16.2 Disinfectants 	</h4></p>
						<p> chlorine base compound 		Powder: (0.1% available chlorine) for solution.</p>
						<p> chloroxylenol 		Solution: 4.8%.</p>
						<p>glutaral 		Solution: 2%.</p>
						
<!-                 </article>
                </section>
			
			
			
            </main>
        </div>
    </div>

</section>

<!-- home section ends -->

<!-- about section ends -->

<!-- facility section starts  -->

<section class="facility" id="facility">

<div class="container">

<h1 class="heading"><span></span><span>Facilities</span></h1>


<div class="box-container">
	

		<!-- <img id = "edit1" src="34.png" width = "34px" height="21px" data-aos="fade-right"><img id = "edit1"src="35.jpg" width = "34px" height="21px"data-aos="fade-up">   -->

</div>


        <div class="col-md-6 content" data-aos="fade-right">

            <div class="box">
                <h3> <i class="fas fa-ambulance"></i> Ambulance services </h3>
                <p>currently not available</p>
            </div>

            <div class="box">
                <h3> <i class="fas fa-procedures"></i> Emergency rooms </h3>
                <p>currently not available</p>
            </div>

            <div class="box">
                <h3> <i class="fas fa-stethoscope"></i> Free check-ups </h3>
                <p>currently not available</p>
            </div>
			<div class="box">
                <h3> <i class="fas fa-stethoscope"></i> Contact doctor </h3>
                <p>currently not available</p>
            </div>


        </div>

</div>

</section>

<!-- facility section ends -->


<!-- counter section starts  -->

<section class="counter">

    <div class="container">

    </div>

</section>

<!-- counter section ends -->


<!-- contact section starts  -->

<section class="contact" id="contact">
 

    <div class="container min-vh-100">
        <h1>Contact </h1>
        <div>
            <h3><li>Contact us</li></h3>
            <h4>+91 9988776655/ +21 9877890897</h4>
            <h4>medicoforlife@gmail.com</h4>
            
        </div>

        <div class="row justify-content-center">

            <h1 class="heading"><span>'</span> Make an Appointment <span>'</span></h1>

            <div class="col-md-10" data-aos="flip-down">

                <form action="">

                    <div class="inputBox">
                        <input type="text" placeholder="full name">
                        <input type="number" placeholder="phone">
                    </div>

                    <div class="inputBox">
                        <input type="email" placeholder="your email">
                        <select name="" id="">
                            <option value="" disabled selected>make an appointment</option>
                            <option value="09-11 am">09-11 am</option>
                            <option value="11-03 pm">11-03 pm</option>
                            <option value="03-06 pm">03-06 pm</option>
                            <option value="06-09 pm">06-09 pm</option>
                        </select>
                    </div>

                    



                    <textarea name="" id="" cols="30" rows="10" placeholder="message ( optional )"></textarea>

                    <input onclick="fn1()" type="submit" name="" id="" value="make appointment" class="button">

                </form>

            </div>

        </div>

    </div>

</section>
<script>
function fn1()
{
	alert("Can,t make appointment right now!! Maybe try later :\)")
}


</script>
<!-- contact section ends -->


<!-- footer section starts  -->

<section class="footer">

    <div class="container">

        <div class="row">
            <div class="col-md-4 text-center" data-aos="fade-up">
                <h4> Links</h4>
                <a href="#home">home</a>
                <a href="#facility">facilites</a>
                <a href="#contact">contact</a>
            </div>

            <div class="col-md-4 text-center" data-aos="fade-left">
                <h4>Share</h4>
                <a href="#" onclick="function(d, s, id)"></a>


				<div id="fb-root"></div>
<script>
    
    (function(d, s, id) {
var js, fjs = d.getElementsByTagName(s)[0];
if (d.getElementById(id)) return;
js = d.createElement(s); js.id = id;
js.src = "https://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v3.0";
fjs.parentNode.insertBefore(js, fjs);
}(document, 'script', 'facebook-jssdk'));</script>

<!-- Your share button code -->
<div class="fb-share-button" 
data-href="https://med1ife.github.io/medico/" 
data-layout="button_count">
</div>


               
            </div>

        </div>

    </div>

    <h1 class="credit text-center mx-auto">created by <span>Students.I2IT</span> | all rights reserved.</h1>

</section>

<!-- footer section ends -->

<!-- jquery cdn link  -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.5.1/jquery.min.js"></script>

<!-- magnific popup js link  -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/magnific-popup.js/1.1.0/jquery.magnific-popup.min.js"></script>

<!-- aos js file cdn link  -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/aos/2.3.4/aos.js"></script>

<!-- custom js link  -->
<script src="js/main.js"></script>

<script>

AOS.init({
    duration:1000,
    delay:400
}); 

</script>

</body>
</html>

<style>
.container{
	background-image:url("21.jpg");
	
}

.nav-link{

	background-image:url("26.jpg")
}

.container-fluid{

	background-image:url("21.jpg");

}
#edit1{
    margin:10px
}
#edit5{
	margin:100px
}
/* Core Styles */

body {
    margin: 0;
    font-family: Arial, Helvetica, sans-serif;
    background: rgb(253, 251, 251);
    color: rgb(0, 0, 0);
    font-size: 1.7em;
    line-height: 1.2;
    text-align: left;
  }

  img {
    display: block;
    width: 100%;
    height: auto;
  }

  h1,
  h2,
  h3 {
    margin: 0;
    padding: 1em 0;
  }

  p {
    margin: 0;
    padding: 1em 0;
  }

  .btn {
    display: inline-block;
    background: #333;
    color: #fff;
    text-decoration: none;
    padding: 1em 2em;
    border: 1px solid #666;
    margin: 0.5em 0;
  }

  .btn:hover {
    background: #eaeaea;
    color: #333;
  }

  /* Header Showcase */

  #showcase {
    min-height: 450px;
    color: #fff;
    text-align: center;
  }

  #showcase .bg-image {
    position: absolute;
    background: #333
      url("2.jpg");
    background-position: center;
    background-repeat: no-repeat;
    background-size: cover;
    width: 100%;
    height: 450px;
    z-index: -1;
    opacity: 1;
  }

  #showcase h1 {
    padding-top: 100px;
    padding-bottom: 0;
  }

  #showcase .content-wrap,
  #section-a .content-wrap {
    padding: 0 1.5em;
  }

  /* Section A */

  #section-a {
    background: #eaeaea;
    color: #333;
    padding-bottom: 2em;
  }

  /* Section B */

  #section-b {
    padding: 2em 1em 1em;
  }

  #section-b ul {
    list-style: none;
    margin: 0;
    padding: 0;
  }

  #section-b li {
    margin-bottom: 1em;
    background: #fff;
    color: #333;
  }

  .card-content {
    padding: 1.5em;
  }

  /* Section C */

  #section-c {
    background: #fff;
    color: #333;
    padding: 2em;
  }

  /* Section D / Boxes */

  #section-d .box {
    padding: 2em;
    color: #fff;
  }

  #section-d .box:first-child {
    background: #2690d4;
  }

  /* Footer */

  #main-footer {
    padding: 2em;
    background: #000;
    color: #fff;
    text-align: center;
  }

  #main-footer a {
    color: #2690d4;
    text-decoration: none;
  }

  /* Media Queries */

  @media (min-width: 700px) {
    .grid {
      display: grid;
      grid-template-columns: 1fr repeat(2, minmax(auto, 25em)) 1fr;
    }

    #section-a .content-text {
      columns: 2;
      column-gap: 2em;
      
    }

    #section-a .content-text p {
      padding-top: 0;
    }

    .content-wrap,
    #section-b ul {
      grid-column: 2/4;
    }

    .box,
    #main-footer div {
      grid-column: span 2;
    }

    #section-b ul {
      display: flex;
      justify-content: space-around;
    }

    #section-b li {
      width: 31%;
    }
  }

</style>
